We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Machine Learning Radically Reduces Workload of Cell Counting for Disease Diagnosis

By LabMedica International staff writers
Posted on 24 May 2022
Print article
Image: New training method allows machine learning to more accurately count blood cells (Photo courtesy of Pexels)
Image: New training method allows machine learning to more accurately count blood cells (Photo courtesy of Pexels)

Machine learning methods are increasingly spreading into the area of blood cell counting, until recently dominated by expensive and often less accurate traditional cell analyzers. However, due to the enormous amount of manual annotation work required, training the machine learning model has so far proven highly labor-intensive. Now, researchers have developed an innovative training method that automates much of this activity.

Researchers at Benihang University (Beijing, China) have developed the new scheme for training a convolutional neural network (CNN) - a type of machine learning that mirrors the connection structure of the human visual cortex. The number and type of cells in the blood often play a crucial role in disease diagnosis, but the cell analysis techniques commonly used to perform such counting of blood cells - involving the detection and measurement of physical and chemical characteristics of cells suspended in fluid - are expensive and require complex preparations. Worse still, the accuracy of cell analyzer machines is only about 90% due to various influences such as temperature, pH, voltage, and magnetic field that can confuse the equipment.

In order to improve accuracy, reduce complexity and lower costs, much research into alternatives has lately focused on the use of computer programs to perform “segmentation” on photographs of the blood taken by a high-definition camera connected to a microscope. Segmentation involves algorithms that perform pixel-by-pixel labeling of what appears in a photo, in this case, what parts of the image are cells and which are not - in essence, counting the number of cells in an image. For images in which only a single type of cell appears, such methods achieve a decent level of accuracy, but they perform poorly when confronting images with multiple types of cells. So in recent years, in attempts to solve the problem, researchers have turned to CNNs.

For the CNN to perform this task, it must first be “trained” to understand what is and is not a cell on many thousands of images of cells that humans have manually labeled. Then, when fed a novel, unlabelled image, it recognizes and can count the cells in it. The researchers at Beihang University developed a new scheme for training the CNN, in this case, U-Net, a fully convolutional network segmentation model that has been widely used in medical image segmentation since it was first developed in 2015. In the new training scheme, the CNN is first trained on a set of many thousands of images with only one type of cell (taken from the blood of mice).

These single-cell-type images are “preprocessed” automatically by conventional algorithms that reduce noise in the images, enhance their quality, and detect the contours of objects in the image. They then perform adaptive image segmentation. This latter algorithm calculates the various levels of gray in a black and white image, and if a part of the image lies beyond a certain threshold of gray, the algorithm segments that out as a distinct object. What makes the process adaptive is that rather than segmenting out parts of the image segments according to a fixed gray threshold, it does this according to the local features of the image.

After the single-cell-type training set is presented to the U-Net model, the model is fine-tuned using a small set of manually annotated images of multiple cell types. In comparison, a certain amount of manual annotation remains, and the number of images needed to be labeled by humans drops from what was previously many thousands to just 600. To test their training scheme, the researchers first used a traditional cell analyzer on the same mouse blood samples to do an independent cell count against which they could compare their new approach. They found that the accuracy of their training scheme on segmentation of multiple-cell-type images was 94.85%, which is the same level achieved by training with manually annotated multiple-cell-type images. The technique can also be applied to more advanced models to consider more complex segmentation problems. As the new training technique still involves some level of manual annotation, the researchers hope to go on to develop a fully automatic algorithm for annotating and training models.

Related Links:
Benihang University 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Molecular Diagnostics

view channel
Image: AI analysis of DNA fragmentomes and protein biomarkers noninvasively detects ovarian cancer (Photo courtesy of Adobe Stock)

Blood-Based Machine Learning Assay Noninvasively Detects Ovarian Cancer

Ovarian cancer is one of the most common causes of cancer deaths among women and has a five-year survival rate of around 50%. The disease is particularly lethal because it often doesn't cause symptoms... Read more

Immunology

view channel
Image: The groundbreaking treatment approach has shown promise in hard-to-treat cancers (Photo courtesy of 123RF)

Genetic Testing Combined With Personalized Drug Screening On Tumor Samples to Revolutionize Cancer Treatment

Cancer treatment typically adheres to a standard of care—established, statistically validated regimens that are effective for the majority of patients. However, the disease’s inherent variability means... Read more

Pathology

view channel
Image: The device can serve as a sample pretreatment tool for cytological diagnosis of malignant effusions (Photo courtesy of Microsystems & Nanoengineering: Zhu, Z., Ren, H., Wu, D. et al.)

Microfluidic Device for Cancer Detection Precisely Separates Tumor Entities

Tumor cell clusters are increasingly recognized as crucial in cancer pathophysiology, with growing evidence of their increased resistance to treatment and higher metastatic potential compared to single tumor cells.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.